SUNNYVALE, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Cepheid will present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference being held at the New York Palace Hotel, New York, New York, November 7-9, 2005. Chief Executive Officer John L. Bishop and Senior Vice President, Finance and Chief Financial Officer, John R. Sluis will present at 8:40 a.m. Eastern on Wednesday, November 9, 2005.
Rodman & Renshaw will provide a live webcast of the audio presentation available at the following address: http://www.wsw.com/webcast/rrshq7/cphd/. The webcast, along with accompanying presentation slides, may also be accessed on the Company’s web site at www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentation will be available for 90 days.
About Cepheid
Cepheid , based in Sunnyvale, Calif., is a leading developer, manufacturer and marketer of fully integrated systems that enable genetic assessment when and where it is needed. Founded in 1996, the company is commercializing its technology and products worldwide for research, medical, and industrial applications requiring assessment of the human genome, infectious disease and biothreat agents. See www.cepheid.com for more information.
CONTACTS At the Company: John L. Bishop John R. Sluis CEO, Cepheid CFO, Cepheid 408-541-4191 408-541-4191 john.bishop@cepheid.comjohn.sluis@cepheid.com Financial Relations Board: Tricia Ross Investor/Analyst Information 617-520-7064 tross@financialrelationsboard.com
Cepheid
CONTACT: John L. Bishop, CEO, john.bishop@cepheid.com, or John R. Sluis,CFO, john.sluis@cepheid.com, both of Cepheid, +1-408-541-4191; orInvestor/Analyst Information, Tricia Ross of Financial Relations Board,+1-617-520-7064, tross@financialrelationsboard.com, for Cepheid
